nach oben

Abdominal Radiology

Erschienen in:

01.04.2007

Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging

verfasst von: Joan C. Vilanova, Joaquim Barceló

Erschienen in: Abdominal Radiology | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance spectroscopic imaging (MRSI) represents a noninvasive technique to extend the diagnostic evaluation of prostatic cancer, beyond the morphologic information provided by MR imaging throughout the detection of cellular metabolites (choline and citrate). MRSI combined with the anatomical information provided by MRI can improve the assessment cancer location and extent within the prostate, extracapsular spread and cancer aggressiveness; both before and after treatment. We review the performance of MRI with MRSI and the role in the detection, localization, staging and management of the patient pre- and posttherapy for prostate cancer.

Gilliland FD, Hunt WC, Key CR (1996) Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era. Urology 48:67–71PubMedCrossRef

Cooperberg MR, Lubeck DP, Grossfeld GD, et al. (2002) Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavour. J Urol 168:491–495PubMedCrossRef

Kurhanewicz J, Swanson MG, Nelson SJ, et al. (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16:451–463PubMedCrossRef

Rajesh A, Coakley FV (2004) MR imaging and MR spectroscopic imaging of prostate cancer. Magn Reson Imaging Clin North Am 12:557–579CrossRef

Tsuda K, Yu KK, Coakley FV, et al. (1999) Endorectal MR imaging of prostate cancer: role of fat suppresion in the detection of extracapsular detection. J Comput Assist Tomogr 23:74–78PubMedCrossRef

Rouvière O, Raudrant A, Ecochard R et al. (2003) Characterization of timeenhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13:931–941PubMed

Prezioso P, Orlacchio A, Giambattista GD, et al. (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13:925–930

Van Dorsten FA, Van der Graaf M, Engelbrecht MRW, et al. (2004) Combined quantitative dynamic contrast-enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20:279–287PubMedCrossRef

Engelbrecht M, Huisman HJ, Laheij RJF, et al. (2003) Discrimination of prostate cancer from peripheral zone and central gland tissue using dynamic contrast-enhanced MR imaging. Radiology 229:248–254PubMedCrossRef

10.

Jung JA, Coakley FV, Qayyum A, et al. (2004) Endorectal MR spectroscopic imaging of the prostate:investigation of a standardized evaluation system. Radiology 233:701–708PubMedCrossRef

11.

Kurhanewicz J, Vigneron DB, Hricak H, et al. (1986) Three dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm³) spatial resolution. Radiology 198:795–805

12.

Kurhanewicz J, Vigneron DB, Males RG, et al. (2000) The prostate: MR imaging and spectroscopy: present and future. Radiol Clin North Am 38:115–138PubMedCrossRef

13.

Qayyum A, Coakley FV, Lu Y, et al. (2004) Effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 183:1079–1083PubMed

14.

Vilanova JC, Comet J, Capdevila A, et al. (2001) The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients. Eur Radiol 11:229–235PubMedCrossRef

15.

Cruz M, Tsuda K, Narumi Y, et al. (2002) Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 12:357–365PubMedCrossRef

16.

Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167–S180PubMedCrossRef

17.

Scheidler J, Hedvig Hricak H, Vigneron DB, et al. (1999) Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213:473–480PubMed

18.

Kaji Y, Kurhanewicz J, Hricak H, et al. (1998) Localizing prostate cancer in the presence of post-biopsy changes on MR imaging: role of proton MR spectroscopic imaging. Radiology 206:785–790PubMed

19.

Beyersdorff D, Taupitz M, Winkelmann B, et al. (2002) Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224:701–706PubMedCrossRef

20.

Perrotti M, Han KR, Epstein RE, et al. (1999) Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 162:1314–1317PubMedCrossRef

21.

Comet-batlle J, Vilanova-Busquets JC, Saladie-Roig JM, et al. (2003) Endorectal MRI in the early diagnosis of prostate cancer. Eur Urol 44:201–208PubMedCrossRef

22.

Vilanova JC, Comet J, Barceló AJ, et al. (2004) The value of MR spectroscopic imaging for prostate cancer detection in the peripheral and transitional zone in patients with elevated PSA and negative biopsy (abstr). Radiology (p) 233:270

23.

Zakian KL, Eberhardt S, Hricak H, et al. (2003) Transition zone prostate cancer: metabolic characteristics at 1H spectroscopic imaging-initial results. Radiology 229:241–247PubMedCrossRef

24.

Zakian KL, Sircar K, Hricak H, et al. (2005) Correlation of Proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234:804–814PubMedCrossRef

25.

Yu KK, Scheidler J, Hricak H (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488PubMed

26.

Wefer AE, Hricak H, Vigneron DB, et al. (2000) Sextant location of prostate cancer : comparison od sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step-section histology. J Urol 164:400–404PubMedCrossRef

27.

Purohit RS, Shinohara K, Meng MV, Carrol PR (2003) Imaging clinically localized prostate cancer. Urol Clin North Am 30:279–293PubMedCrossRef

28.

Huch Boni RA, Boner JA, Debatin JF, et al. (1995) Optimization of prostate carcinoma staging:comparison of imaging and clinical methods. Clin Radiol 50:593–600PubMedCrossRef

29.

Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, Van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302PubMed

30.

Jager GJ, Ruijter ET, van de Kaa CA, et al. (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166:845–852PubMed

31.

Cornoud F, Flam T, Chauveinc L, et al. (2002) Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging. Radiology 224:203–210CrossRef

32.

Wang L, Mullerad M, Chen HN, et al. (2004) Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 232:133–139PubMedCrossRef

33.

Coakley FV, Kurhanewicz J, Lu Y, et al. (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223:91–97PubMedCrossRef

34.

Partin AW, Hanks GE, Klein EA, et al. (2002) Prostate-specific antigen as a marker of disease activity in prostate cancer. Oncology 16:1024–1038PubMed

35.

Sella T, Schwartz LH, Swindle PW, et al. (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379–385PubMedCrossRef

36.

Coakley FV, The HS, Qayyum A, et al. (2004) Endorectal and MR spectroscopic imaging of locally recurrent prostate cancer after external beam radiation theraphy: preliminary experience. Radiology 233:441–448PubMedCrossRef

37.

Mueller-Lisse UG, Vigneron DB, Hricak H, et al. (2001) Localized prostate cancer:effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology 221:380–390PubMedCrossRef

38.

Vilanova JC, Barceló J (2005) Pelvis masculina: Próstata y testículos. In: Martí Bonmatí L, Vilanova JC (eds). Resonancia Magnética de Cuerpo. Edikamed, Barcelona, pp 149–162

Titel: Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging
verfasst von: Joan C. Vilanova
Joaquim Barceló
Publikationsdatum: 01.04.2007
Verlag: Springer-Verlag
Erschienen in: Abdominal Radiology / Ausgabe 2/2007
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-007-9191-7

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging

Abstract

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Diverticulitis of the small bowel: CT diagnosis

Severity prediction in acute pancreatitis: the role of early CT scan

Ultrasonography of the pancreas. 7. Intraoperative imaging

Acute adrenal hemorrhage after blunt trauma

Biliary atresia in infants with prolonged cholestatic jaundice: diagnostic accuracy of hepatobiliary scintigraphy

Ultrasonography of the pancreas. 5. Interventional procedures

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie